Fusion of NUP214 to ABL1 on amplified episomes in T-ALL--implications for treatment.
Stergianou
K
K
Fox
C
C
Russell
N H
NH
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D019677:Artificial Gene Fusion; D001549:Benzamides; D005784:Gene Amplification; D016313:Genes, abl / Q000235:genetics*; D006801:Humans; D000068877:Imatinib Mesylate; D017404:In Situ Hybridization, Fluorescence; D015459:Leukemia-Lymphoma, Adult T-Cell / Q000188:drug therapy* / Q000235:genetics*; D008297:Male; D028861:Nuclear Pore Complex Proteins / Q000235:genetics*; D010879:Piperazines / Q000627:therapeutic use*; D010957:Plasmids / Q000235:genetics*; D011743:Pyrimidines / Q000627:therapeutic use*; D012008:Recurrence
D001549:Benzamides; C085914:NUP214 protein, human; D028861:Nuclear Pore Complex Proteins; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate